Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Involvement of CCL2 in Salivary Gland Response to Hyperosmolar Stress Related to Sjögren’s Syndrome

Title: Involvement of CCL2 in Salivary Gland Response to Hyperosmolar Stress Related to Sjögren’s Syndrome
Authors: Clara Chivasso; Dorian Parisis; Xavier Cabrol; Azine Datlibagi; Valérie Delforge; Françoise Gregoire; Nargis Bolaky; Muhammad Shahnawaz Soyfoo; Jason Perret; Christine Delporte
Source: International Journal of Molecular Sciences, Vol 25, Iss 2, p 915 (2024)
Publisher Information: MDPI AG
Publication Year: 2024
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: hyperosmotic stress; salivary gland epithelial cells; CCL2; inflammation; Sjögren’s syndrome; Biology (General); QH301-705.5; Chemistry; QD1-999
Description: In primary Sjögren’s syndrome (pSS) patients, salivary gland (SG) epithelial cells (SGECs) could be exposed to chronic hyperosmotic stress (HOS), consecutive to their destruction and deregulation, that exacerbates an inflammatory response. The aims of this study were to assess the mechanism accounting for C-C motif chemokine ligand 2 (CCL2) expression in an immortalized human salivary gland epithelial acinar cell line (NS-SV-AC) subjected to HOS, as well as the involvement of CCL2 in pSS. CCL2 mRNA and protein levels were determined via RT-qPCR and ELISA. Reporter plasmids and a promoter pull-down assay were used to identify transcription factors associated with CCL2 mRNA increase. Our data showed that HOS-induced CCL2 mRNA increase was independent of the nuclear factor of activated T-cells 5 (NFAT5) and nuclear factor-kappa B (NFkB) but involved Kruppel-like factor 5 (KLF5). CCL2 protein levels, quantified by enzyme-linked immunosorbent assay (ELISA) in sera samples from pSS patients, correlated with the European Alliance of Associations for Rheumatology’s Sjogren’s syndrome disease activity index (ESSDAI) score for systemic activity. In addition, CCL2 protein levels were higher in patients with biological activity, cutaneous manifestations, and ESSDAI score superior or equal to five. Our data suggest that chronic HOS could exacerbate pSS disease by contributing to the inflammatory process induced by the expression and secretion of CCL2.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/1422-0067/25/2/915; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067; https://doaj.org/article/a00bbd4dc21342f5a811fefdf9ca7a2e
DOI: 10.3390/ijms25020915
Availability: https://doi.org/10.3390/ijms25020915; https://doaj.org/article/a00bbd4dc21342f5a811fefdf9ca7a2e
Accession Number: edsbas.7FDFD1A4
Database: BASE